Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Expert Rev Proteomics ; 18(8): 637-642, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34477466

RESUMEN

INTRODUCTION: Lung cancer remains the most prevalent cause of cancer mortality worldwide mainly due to insufficient availability of early screening methods for wide-scale application. Exhaled breath condensate (EBC) is currently considered as one of the promising targets for early screening and is particularly attractive due to its absolutely noninvasive collection and possibility for long-term frozen storage. EBC proteome analysis can provide valuable information about the (patho)physiological changes in the respiratory system and may help to identify in time a high risk of lung cancer. Mass spectrometry (MS) profiling of EBC proteome seems to have no alternative in obtaining the most extensive data and characteristic marker panels for screening. AREAS COVERED: This special report summarizes the data of several proteomic studies of EBC in normal and lung cancer (from 2012 to 2021, PubMed), focuses on the possible reasons for the significant discrepancy in the results, and discusses some aspects for special attention in further studies. EXPERT OPINION: The significant discrepancy in the results of various studies primarily highlights the need to create standardized protocols for the collection and preparation of EBC for proteomic analysis. The application of quantitative and targeted LC-MS/MS based approaches seems to be the most promising in further EBC proteomic studies.


Asunto(s)
Neoplasias Pulmonares , Proteoma , Biomarcadores , Biomarcadores de Tumor , Pruebas Respiratorias , Cromatografía Liquida , Humanos , Pulmón , Neoplasias Pulmonares/diagnóstico , Proteómica , Espectrometría de Masas en Tándem
2.
Chem Biol Interact ; 334: 109339, 2021 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-33316227

RESUMEN

Clinical trials of thermoheliox application (inhalation with a high-temperature mixture of oxygen and helium, 90 °C) in the treatment of the acute phase of coronavirus infection were conducted. Dynamics of disease development in infected patients (PCR test for the virus) and, dynamics of changes in blood concentration of C-reactive protein, immunoglobulin M, specific immunoglobulin G were studied. High efficiency of thermoheliox in releasing the organism from the virus and stimulating the immune response (thermovaccination effect) was shown. The kinetic model of the process is proposed and analyzed.


Asunto(s)
COVID-19/inmunología , COVID-19/terapia , Helio/administración & dosificación , Hipertermia Inducida/métodos , Oxígeno/administración & dosificación , Administración por Inhalación , Adulto , Anciano , Anticuerpos Antivirales/sangre , Proteína C-Reactiva/biosíntesis , COVID-19/virología , Calor , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Cinética , Persona de Mediana Edad , Modelos Inmunológicos , SARS-CoV-2/inmunología , Vacunación/métodos
3.
Int J Mol Sci ; 20(18)2019 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-31547269

RESUMEN

Comprehensive studies of the effects of prolonged exposure to space conditions and the overload experienced during landing on physiological and biochemical changes in the human body are extremely important in the context of planning long-distance space flights, which can be associated with constant overloads and various risk factors for significant physiological changes. Exhaled breath condensate (EBC) can be considered as a valuable subject for monitoring physiological changes and is more suitable for long-term storage than traditional monitoring subjects such as blood and urine. Herein, the EBC proteome changes due to the effects of spaceflight factors are analyzed. Thirteen EBC samples were collected from five Russian cosmonauts (i) one month before flight (background), (ii) immediately upon landing modules in the field (R0) after 169-199 days spaceflights, and (iii) on the seventh day after landing (R+7). Semi-quantitative label-free EBC proteomic analysis resulted in 164 proteins, the highest number of which was detected in EBC after landing (R0). Pathways enrichment analysis using the GO database reveals a large group of proteins which take part in keratinization processes (CASP14, DSG1, DSP, JUP, and so on). Nine proteins (including KRT2, KRT9, KRT1, KRT10, KRT14, DCD, KRT6C, KRT6A, and KRT5) were detected in all three groups. A two-sample Welch's t-test identified a significant change in KRT2 and KRT9 levels after landing. Enrichment analysis using the KEGG database revealed the significant participation of detected proteins in pathogenic E. coli infection (ACTG1, TUBA1C, TUBA4A, TUBB, TUBB8, and YWHAZ), which may indicate microbiota changes associated with being in space. This assumption is confirmed by microbial composition analysis. In general, the results suggest that EBC can be used for noninvasive monitoring of health status and respiratory tract pathologies during spaceflights, and that the obtained data are important for the development of medicine for use in extreme situations. Data are available from ProteomeXchange using the identifier PXD014191.


Asunto(s)
Pruebas Respiratorias/métodos , Proteoma/análisis , Vuelo Espacial , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/microbiología , Humanos , Mapas de Interacción de Proteínas , Proteoma/metabolismo , Proteómica/métodos , Espectrometría de Masas en Tándem/métodos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA